Literature DB >> 8295629

Mortality from congestive heart failure--United States, 1980-1990.

.   

Abstract

In the United States, congestive heart failure (CHF) was the underlying cause of death for approximately 38,000 persons in 1990; of those deaths, approximately 92% were among persons aged > or = 65 years. CHF, a clinical syndrome defined as a chronic inadequate contraction of the heart muscle resulting in insufficient cardiac output, is a manifestation of one or more underlying conditions, including systemic or pulmonary hypertension or a history of other heart diseases (e.g., myocardial infarction, atherosclerosis, cardiomyopathy, congenital heart disease, or rheumatic fever). The long-term prognosis of CHF depends on the underlying condition and the response of that condition to treatment. Despite declines in death rates for ischemic heart disease and cerebrovascular disease, improvements in detection and treatment of hypertension, and considerable advances in the diagnosis and management of CHF, mortality from CHF has increased since 1980. This report summarizes trends in CHF mortality in the United States during 1980-1990 and presents state-specific mortality data for 1990 (the most recent year for which such data are available).

Entities:  

Mesh:

Year:  1994        PMID: 8295629

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  5 in total

1.  Identifying sick children requiring referral to hospital in Bangladesh.

Authors:  H D Kalter; J A Schillinger; M Hossain; G Burnham; S Saha; V de Wit; N Z Khan; B Schwartz; R E Black
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

2.  Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis.

Authors:  Hossein Bahrami; Richard Kronmal; David A Bluemke; Jean Olson; Steven Shea; Kiang Liu; Gregory L Burke; João A C Lima
Journal:  Arch Intern Med       Date:  2008-10-27

3.  Determining the effectiveness of torasemide and furosemide in heart failure: design of a randomised comparison using the regenstrief medical record system.

Authors:  M D Murray; W M Tierney; D C Brater
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

4.  Enter Stage A, Exit Stage D: A Curtain Call for Delay in Heart Failure Prevention.

Authors:  Nosheen Reza; Mariell Jessup
Journal:  Circ Heart Fail       Date:  2019-09-11       Impact factor: 8.790

5.  Clinical signs of pneumonia in children attending a hospital outpatient department in Lesotho.

Authors:  S C Redd; R Vreuls; M Metsing; P H Mohobane; E Patrick; M Moteetee
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.